BB Biotech AG (BB Biotech AG) Operating Cash Flow per Share : $4.31 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BB Biotech AG Operating Cash Flow per Share?

BB Biotech AG's operating cash flow per share for the three months ended in Dec. 2023 was $-0.02. BB Biotech AG's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.31.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BB Biotech AG was -5.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for BB Biotech AG's Operating Cash Flow per Share or its related term are showing as below:

BBAGF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -25.8 Med: 0.5 Max: 50
Current: -5.6

During the past 13 years, BB Biotech AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.00% per year. The lowest was -25.80% per year. And the median was 0.50% per year.

BBAGF's 3-Year OCF Growth Rate is ranked worse than
61.54% of 1235 companies
in the Biotechnology industry
Industry Median: 3.5 vs BBAGF: -5.60

BB Biotech AG Operating Cash Flow per Share Historical Data

The historical data trend for BB Biotech AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Operating Cash Flow per Share Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

3.95

5.33

-1.86

4.51

4.60

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-1.18	4.00	0.17	0.15	-0.02

Competitive Comparison of BB Biotech AG's Operating Cash Flow per Share

For the Biotechnology subindustry, BB Biotech AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Price-to-Operating-Cash-Flow falls into.

BB Biotech AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

BB Biotech AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	252.401	/	54.846
	=	4.60

BB Biotech AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-1.073	/	54.846
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.31

BB Biotech AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (BB Biotech AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines